Possible explanations for the findings could be the AML cohort, cohort size, fluorochrome choice, clone choice, and the use of the GMFI threshold for CD9 expression in our study (as opposed to positive vs negative). This evidence concerns the gene CD9 and acute myeloid leukemia.